{"data":[{"accessionNo":"0001346824-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-23","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1914788,"percentOfClass":9.9,"filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001346824-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-23","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":1914788,"percentOfClass":9.9,"filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001346824-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-23","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":1914788,"percentOfClass":9.9,"filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001346824-26-000243","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-09-23","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1914788,"percentOfClass":9.9,"filedAt":"2026-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":206354,"percentOfClass":1.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":206354,"percentOfClass":1.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":206354,"percentOfClass":1.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":206354,"percentOfClass":1.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-26-097066","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0002012383-26-002244","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"CORBUS PHARMACEUTICALS HOLDINGS INC","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1093434,"percentOfClass":5.9,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-006202","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-006202","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-006202","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":"21833P301","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":955000,"percentOfClass":5.4,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Octagon Investments Master Fund LP","reportingCik":null,"personType":"PN,OO","sharesOwned":955000,"percentOfClass":5.4,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001214659-26-001397","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":955000,"percentOfClass":5.4,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001716774-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Aberdeen Group plc","reportingCik":null,"personType":"HC","sharesOwned":1321750,"percentOfClass":7.53,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001716774-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"abrdn Inc.","reportingCik":null,"personType":"CO,IA","sharesOwned":1321750,"percentOfClass":7.53,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0000929638-25-004599","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2344971,"percentOfClass":13.36,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0000929638-25-004599","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"Chen Bihua","reportingCik":null,"personType":"IN,HC","sharesOwned":2344971,"percentOfClass":13.36,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001172661-25-004964","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-03","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2375000,"percentOfClass":12.82,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001172661-25-004964","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-03","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2375000,"percentOfClass":12.82,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":980610,"percentOfClass":5.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":873313,"percentOfClass":4.7,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":873313,"percentOfClass":4.7,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":873313,"percentOfClass":4.7,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":107297,"percentOfClass":0.6,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":107297,"percentOfClass":0.6,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"},{"accessionNo":"0001104659-25-110417","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001595097","issuerName":"Corbus Pharmaceuticals Holdings, Inc.","ticker":"CRBP","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-11-04","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":107297,"percentOfClass":0.6,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/crbp"}],"updatedAt":"2026-10-25T00:16:53.531Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/crbp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}